Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients
Status:
Withdrawn
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate safety and tolerability of an immediate
conversion from Tacrolimus to everolimus in stable renal allograft recipients.
Interest in developing CNI-free regimens using other agents such as the proliferation signal
inhibitor everolimus.